We're pleased to announce that it has secured a further Australian Innovation Patent related to its Virtual Reality concussion diagnostic technology.
An Australian Innovation Patent (Patent No. 20121107529) has been awarded to HITIQ for “Technology Adapted for Improved Assessment of Cognitive Function in A Human Subject, Including Assessment of Cognitive Function Affected By Brain Injuries Sustained During Sporting Activities”.
Key features of the patent cover the combining of data from HITIQ’s virtual reality testing platform with data from HITIQ instrumented mouthguard technology, including:
- Performing VR-based neurological assessments on a human subject;
- Constructing and delivering a series of cognitive tests of varied test class, thereby to increase cognitive load on the test subject; and
- Triggering testing and/or presenting test results in combination with impact data from an instrumented mouthguard device.
The combined process allows a deeper understanding of relationships between impacts, for example in a sporting environment, and cognitive performance. This relationship as considered in terms of impact magnitude and cognitive impairment, is of significant utility in injury assessment and ongoing management. Being an Innovation Patent, the associated rights are especially robust to withstand validity attacks from third parties.